Navigation Links
Haemacure to Present at the BioFinance 2008 Conference to be held at the Toronto Marriott Eaton Centre, May 6 - 8, 2008
Date:5/1/2008

HAE:TSX

MONTREAL, May 1 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX : HAE), a Montreal-based specialty bio-therapeutics company developing high-value human plasma-derived protein products for commercialization, announced today that Joseph Galli, Chairman and Chief Executive Officer, will present at BioFinance 2008 on Thursday, May 8th at 11:00am ET, in the Trinity Room at The Toronto Marriott Eaton Centre, Toronto, Ontario.

BioFinance 2008 is the Canadian Life Science industry's leading investor conference. The meeting brings together key industry players to consider investment opportunities and issues affecting companies in biotechnology, medical devices, diagnostics and research tools. Participants include senior life science executives, institutional and venture capital investors, industry analysts, corporate finance executives and experts from the scientific and medical communities in Canada, the United States, Europe and Asia.

About Haemacure

Haemacure Corporation is a specialty biotherapeutics company developing high-value human plasma-derived protein products for commercialization. Haemacure's research and development effort is driven by its proprietary plasma protein extraction technology to develop next-generation products, including surgical hemostats. Haemacure's lead product candidate, Hemaseel(R)HMN, is a fibrin sealant planned to enter pivotal Phase II/Phase III clinical trials during the first quarter of 2009. Haemacure's second product candidate is thrombin, a component of its fibrin sealant, now in preclinical stage. Follow-on development will focus on surgical hemostats, wound healing, adhesion prevention, regenerative medecine, drug delivery and combination with biomaterials. Haemacure has discovered eleven additional specialty proteins and enzymes in one if its two plasma fractions and seeks to advance these proteins and enzymes through partnerships with pharmaceutical and b
'/>"/>

SOURCE HAEMACURE CORPORATION
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Haemacure Discloses Positive Results of a preclinical study of its fibrin sealant in adhesion prevention and opens a new opportunity in a market with a significant unmet medical need
2. Haemacure Reports on its annual general and special meeting of shareholders
3. Media Invitation - Annual General and Special Meeting of Shareholders of Haemacure
4. Haemacure Announces Details of its Annual General and Special Meeting of Shareholders
5. Haemacure announces webcast of presentation at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conferencec
6. Haemacure Adopts Strategy for "First-Patient-In" Fibrin Sealant Pivotal Clinical Trials
7. Haemacure Reports Third Quarter 2007 Results
8. Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology Meeting
9. MedCath Corporation to Present at the Deutsche Bank Securities 33rd Annual Health Care Conference
10. Hospira to Present at the Bank of America 2008 Health Care Conference on May 14
11. EAU Technologies to Present at AeA Micro Cap Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... Cannabis use among young people has spiked, ... 17 having used marijuana at least once and 17 percent ... ‘No’ to Drugs, Say ‘Yes to Life,’ volunteers from the ... this summer with factual information about drugs, to help reverse ... “Say ‘No’ to Drugs, Say ‘Yes’ to Life,” volunteers have ...
(Date:8/1/2014)... in regulating appetite and whole-body metabolism. A protein known ... food intake and body weight, but the identity of ... A new study in the Journal of ... type of neuron known as pro-opiomelanocortin (POMC) neurons is ... Sabrina Diano and colleagues at Yale University School of ...
(Date:8/1/2014)... 1, 2014 (HealthDay News) -- The U.S. Food and ... new drug, Jardiance, to help fight type 2 diabetes. ... added to existing treatment regimens to control blood sugar ... Rosebraugh, director of the Office of Drug Evaluation II ... said in an agency statement. The FDA also ...
(Date:8/1/2014)... Summer is here, and with it comes ... summer, and they can be a pain for dogs. Animal ... all their customers get rid of ticks and prevent them ... in the summer, which is why they are so active ... and woodland areas and carry a number of diseases, including ...
(Date:8/1/2014)... and the benefits of a cancer diagnosis may improve ... a study conducted by a researcher at the University ... an expressive writing intervention is the writing instruction. Otherwise, ... events. Writing a journal can be therapeutic, but oftentimes ... it,s effective or not," said Qian Lu, assistant professor ...
Breaking Medicine News(10 mins):Health News:Addressing a Serious Issue Affecting German Teens 2Health News:FDA Approves New Type 2 Diabetes Drug 2Health News:Tis the Season for Tick Prevention 2Health News:Expressive writing may help breast cancer survivors 2Health News:Expressive writing may help breast cancer survivors 3
... in rates between 2005 and 2007 , , THURSDAY, April 16 ... a hazard for U.S. workers, a new government report shows. ... employed adults declined overall between 1994 and 2007, there was ... to a report in the April 17 issue of ...
... cause and effect , , THURSDAY, April 16 (HealthDay News) ... A and C in their diet may be at increased ... of 40 studies conducted between 1980 and 2007 showed that ... vitamin A than those without the disease. The average intake ...
... Va., April 16 An African child dies every ... billion people become ill because of it. About 1 ... year from malaria -- a disease that is entirely ... Fund Senior Program Health Specialist David Shanklin stresses the ...
... Community Measurement issues second annual report on health care ... nationMINNEAPOLIS, April 16 Although the care provided to ... improved since the last report on eight of nine ... quality of care provided to patients on public health ...
... the infection, CDC warns, , , THURSDAY, April 16 (HealthDay ... that while rates of testing for sexually transmitted ... of young, sexually active U.S. women still do not ... Disease Control and Prevention combed through 2000-07 data reported ...
... has found that a painful pelvic affliction associated with ... prostatitis or chronic pelvic pain syndrome (CP/CPPS) is a ... genital pain. , This is the first study ... males, and to show the negative impact that pain, ...
Cached Medicine News:Health News:Lead Exposure in Workplace Still a Problem 2Health News:Low Vitamin A, C Intake Tied to Asthma Risk 2Health News:Every 30 Seconds an African Child Dies from Malaria; Education Key to Prevention 2Health News:Every 30 Seconds an African Child Dies from Malaria; Education Key to Prevention 3Health News:Several Minnesota Medical Groups Improve Care for Patients Served by Minnesota Health Care Programs, but Disparities Gap Remains 2Health News:Several Minnesota Medical Groups Improve Care for Patients Served by Minnesota Health Care Programs, but Disparities Gap Remains 3Health News:Less Than Half of Young Women Screened for Chlamydia 2Health News:Pelvic pain as prevalent in teens as older males, Queen's researchers discover 2
(Date:8/1/2014)... 1, 2014 Research and Markets ... "Global Medical Biosensors Market 2014-2018" report to ... Medical biosensors are used to ... detectors. These biosensors monitor health status, disease betterment, ... methods. They are cost-effective and user-friendly devices. Also, ...
(Date:8/1/2014)... 1, 2014  NxStage Medical, Inc. (Nasdaq: NXTM ... that Jeffrey H. Burbank , Chief Executive Officer, and ... the 34 th Annual Canaccord Genuity Growth Conference being ... , on Wednesday, August 13 th at 4:30 p.m. ... at http://ir.nxstage.com/ .  About NxStage Medical ...
(Date:8/1/2014)... 2014 Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), ... are used to develop, manufacture and sell enzymes and ... industrial enzyme industries, announced today that it will report ... 30, 2014 after market close on Thursday, August 14, ... at 5:00 p.m. Eastern Time to discuss those results. ...
Breaking Medicine Technology:Global Medical Biosensors Market 2014-2018: Key Vendors are Abbott, Bayer, LifeScan and F. Hoffmann-La Roche 2NxStage to Present at the 34th Annual Canaccord Genuity Growth Conference 2Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014 2Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014 3
... Alere Inc. (NYSE: ALR ) ("Alere") announced ... totaling $2.1 billion.  Jefferies Finance LLC, GE Capital Markets, ... as joint lead arrangers for the credit facilities, and ... for the lenders under the credit facilities. ...
... Qmed.com , a UBM Canon publishing group brand ... directory and search engine, announced its supplier profiles are ... websites. This new search functionality allows medical device professionals ... paid listings) in search results when they conduct keyword ...
Cached Medicine Technology:Alere Inc. Announces $2.1 Billion Credit Facilities 2Qmed Profiles Searchable Across All Medical Device Websites 2Qmed Profiles Searchable Across All Medical Device Websites 3
Femoral selective diagnostic catheter. The material used is nylon (VESTANTM). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
... a complete offering of cardiology catheters. Available ... catheters are designed with excellent torque, new ... better push-ability, and large inner lumens for ... 6 and 7 French sizes with pressure ...
The Compass Commander series is engineered to provide the discriminating neurosurgeon with the same capabilities offered within the commander plus+, all in a smaller, lower-cost package....
Used for access and catheterization procedures. Double flexible tipped design permits alternative use of both ends of wire guide depending upon procedural needs. Supplied sterile in peel-open package...
Medicine Products: